NanoString Technologies reported after the close of the market on Tuesday that its total revenues declined 28 year over year as collaboration revenues shrank more than threefold.

For the three months ended June 30, total revenues came in at $25 million, down from $34.6 million a year ago when revenues were influenced by significant deferred influx from pharma collaborations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.